ALNA

Allena Pharmaceuticals (ALNA)

Allena Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ALNA

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/11/15	06 : 04	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/09/14	22 : 53	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/09/08	05 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/08/25	05 : 18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/08/11	21 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/08/05	05 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/07/14	05 : 12	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/07/13	05 : 15	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/07/13	05 : 05	GlobeNewswire Inc.	Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/07/11	21 : 55	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/07/11	21 : 53	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/07/05	20 : 14	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/07/05	20 : 00	GlobeNewswire Inc.	Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock Split	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/06/29	05 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/06/24	05 : 46	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/06/23	05 : 07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/05/24	21 : 02	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/05/18	04 : 44	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/05/17	22 : 55	TipRanks	Allena Pharmaceuticals (ALNA) Receives a Hold from H.C. Wainwright	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/05/17	05 : 26	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/05/14	05 : 10	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/05/04	22 : 09	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/05/04	22 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/05/04	22 : 00	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/04/02	01 : 31	TipRanks	Allena Pharmaceuticals (ALNA) Receives a Hold from H.C. Wainwright	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/03/19	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/02/26	06 : 43	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/02/03	06 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/02/03	06 : 16	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALNA	Allena Pharmaceuticals Inc
2022/01/26	06 : 06	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ALNA	Allena Pharmaceuticals Inc